Canaccord Genuity Assigns a Buy Rating on iAnthus Capital Holdings

By Carrie Williams

In a new note to investors yesterday, an analyst has provided a rating update for the Materials sector company, iAnthus Capital Holdings (CNQX: IAN). The company received a Buy rating from Canaccord Genuity’s analyst Matt Bottomley, with a C$4.50 price target.

According to, Bottomley is ranked #2342 out of 4642 analysts.

iAnthus Capital Holdings has an analyst consensus of Moderate Buy, with a price target consensus of C$4.50.

The company has a one year high of C$2.80 and a one year low of C$1.09. Currently, iAnthus Capital Holdings has an average volume of 38.65K.

iAnthus Capital Holdings, Inc. finances and manages licensed cannabis cultivators, processors, and dispensaries. Its portfolio includes Grassroots Vermont, Mayflower Medicinals, Organix, and R. Greenleaf. The company was founded by Hadley Ford and Randy Maslow on November 15, 2013 and is headquartered in New York, NY.